Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CODX | Common Stock | Award | $0 | +12.5K | $0.00 | 12.5K | May 24, 2021 | Direct | F1 | |
transaction | CODX | Common Stock | Tax liability | -$44.5K | -5.63K | -45.02% | $7.90* | 6.87K | May 24, 2021 | Direct | F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CODX | Restricted Stock Units | Options Exercise | $0 | -12.5K | -16.67% | $0.00 | 62.5K | May 24, 2021 | Common Stock | 75K | $0.00 | Direct | F1 |
Id | Content |
---|---|
F1 | Included in 75,000 restricted stock units awarded to the Reporting Person on November 23, 2020, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in 6 equal installments every 6 months commencing on May 24, 2021. |
F2 | Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. |